Oscar Health (OSCR) has reported some challenging numbers recently, but despite a significant earnings miss, its stock jumped nearly 9.6%. It seems investors are looking ahead to 2026, when CEO Mark Bertolini believes the company will finally see profits. They’re banking on a remarkable $750 million turnaround in earnings during that year.
In the last quarter, Oscar’s earnings per share (EPS) came in at -$1.24, falling short of expectations by about 35%. More concerning was the medical loss ratio (MLR), which hit 95.4%. This means for every dollar they earned in premiums, they spent nearly a dollar in medical costs. That’s a tough spot to be in for any business.
So, why the optimism? Bertolini is focusing on three main strategies to drive down costs and increase profits:
AI-Driven Efficiency: Oscar is ramping up its use of artificial intelligence. For example, their AI bot has drastically cut down response times, while their health agent, Oswell, maintains high accuracy in answering member inquiries. This shows that Oscar is not just experimenting with AI; they are integrating it into their operations.
Pricing Discipline: The company is implementing an average rate increase of around 28% for 2026. They are also adjusting for the end of enhanced premium tax credits that attracted riskier members in 2025.
Membership Growth: Oscar’s member count has surged to 3.4 million as of February 2026. A higher member base can help in distributing fixed costs more effectively, and Oscar’s market share has jumped from 17% to 30%.
Additionally, the competition is changing. CVS Health (CVS) has exited the individual ACA exchange marketplace, leaving space for Oscar to expand its footprint.
However, it’s important to note that Bertolini has made similar promises in the past, and the MLR continued to worsen. The upcoming year will require seamless execution of their strategies. With $2.77 billion in cash and a new $475 million credit facility, Oscar has the resources to chase this profitability dream.
As for the broader market, there’s a significant trend in investment toward AI. A notable analyst who once predicted NVIDIA’s massive success has recently identified emerging AI stocks that could see impressive growth. These companies represent various sectors, including equipment and optical networking markets, hinting at a robust future for AI-related investments.
The road ahead is uncertain, but if Oscar can successfully navigate these challenges, it may very well fulfill the promising vision laid out for 2026.
Source link
CVS Health, Mark Bertolini, Oscar Health, medical loss ratio, earnings improvement
